首页> 外文期刊>Asian Journal of Chemistry: An International Quarterly Research Journal of Chemistry >2-(3-Methyl-1-phenyl-1H-pyrazol-4-yl)-3-phenylthiazolidin-4-ones as Potent Antioxidant and Antidiabetic Agent
【24h】

2-(3-Methyl-1-phenyl-1H-pyrazol-4-yl)-3-phenylthiazolidin-4-ones as Potent Antioxidant and Antidiabetic Agent

机译:2-(3-甲基-1-苯基-1H-吡唑-4-基)-3-苯基噻唑烷酮-4-酮作为有效的抗氧化剂和抗糖尿病药

获取原文
获取原文并翻译 | 示例
           

摘要

A series of 2-(3-methyl-1-phenyl-1H-pyrazol-4-yl)-3-phenylthiazolidin-4-ones (7a-7j) were synthesized by intramolecular cyclization of imines (6a-6j) with thioglycolic acid in the presence of acid catalyst. The Schiff bases were obtained upon reaction between electrophil ic carbon atom of 3-methyl-1-phenyl-1 H-pyrazole-4-carbaldehyde (4) and nucleophilic nitrogen atom of substituted aromatic amines, in vino Antioxidant activity was determined by DPPH redical scavenging assay mehod using ascorbic acid as standard. The antidiabetic activity was carried out by streptazocine induced diabetic method using rosiglitazone as standard drug on wister rats. From the study it were found that 3-(4-chlorophenyl)-2-(3-methyl-1-phenyl-1H-pyrazol-4-yl)thiazolidin-4-one (7a), 3-(4-bromophenyl)-2-(3-mefhyl-1-phenyl-1H-pyrazol-4-yl)thiazolidin-4-one (7b), 3-(3,4-dichlorophenyl)-2-(3-methyl-1-phenyl-lH-pyrazol-4-yl)thiazolidin-4-one (7d), 3-(3,4-difluorophenyl)-2-(3-methyl-1-phenyl-1H-pyrazol-4-yl)thiazolidin-4-one (7f) 2-(3-methyl-l -phenyl-1H-pyrazol-4-yl)-3-(4-(trifluoromethyl) phenyl) thiazolidin-4-one (7h). 3-(4-methoxyphenyl)-2-(3-methyl-1-phenyl-1H-pyrazol-4-yl) thiazolidin-4-one (7j) shown more ICso compare to standard. Where as compound 7a, 7b, 7h, 7j show more significant antidiabetic effect against hyperglycemic rats compare to standard drugs at the dose of 5 mg/kg after 21 days of treatment.
机译:通过用巯基乙酸对亚胺(6a-6j)进行分子内环化反应,合成了一系列2-(3-甲基-1-苯基-1H-吡唑-4-基)-3-苯基噻唑烷-4-酮(7a-7j)。在酸催化剂的存在下。 Schiff碱是在3-甲基-1-苯基-1 H-吡唑-4-甲醛(4)的亲电子碳原子与取代的芳族胺的亲核氮原子反应后制得的,并通过DPPH测定了抗氧化活性以抗坏血酸为标准的清除方法。以罗格列酮为标准药物,通过链脲佐菌素诱导的糖尿病方法对大鼠进行抗糖尿病作用。从研究中发现3-(4-氯苯基)-2-(3-甲基-1-苯基-1H-吡唑-4-基)噻唑烷丁-4-酮(7a),3-(4-溴苯基) -2-(3-甲基-1-1-苯基-1H-吡唑-4-基)噻唑烷-4-酮(7b),3-(3,4-二氯苯基)-2-(3-甲基-1-苯基- 1H-吡唑-4-基)噻唑烷-4-(7d),3-(3,4-二氟苯基)-2-(3-甲基-1-苯基-1H-吡唑-4-基)噻唑烷-4-一(7f)2-(3-甲基-1-苯基-1H-吡唑-4-基)-3-(4-(三氟甲基)苯基)噻唑烷-4-(7h)。显示的3-(4-甲氧基苯基)-2-(3-甲基-1-苯基-1H-吡唑-4-基)噻唑烷-4-酮(7j)与标准品相比具有更多的Iso。在治疗21天后,与标准药物相比,化合物7a,7b,7h,7j对高血糖大鼠显示出更显着的抗糖尿病作用,剂量为5 mg / kg。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号